Home Cart Sign in  
Chemical Structure| 31270-80-1 Chemical Structure| 31270-80-1

Structure of 4-Chlorofuro[3,2-c]pyridine
CAS No.: 31270-80-1

Chemical Structure| 31270-80-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 31270-80-1 ]

CAS No. :31270-80-1
Formula : C7H4ClNO
M.W : 153.57
SMILES Code : ClC1=NC=CC2=C1C=CO2
MDL No. :MFCD02179768
InChI Key :OPFFYLJLHPZSEO-UHFFFAOYSA-N
Pubchem ID :2779746

Safety of [ 31270-80-1 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 31270-80-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 9
Fraction Csp3 0.0
Num. rotatable bonds 0
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 39.02
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

26.03 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.89
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.22
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.48
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.18
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.58
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.07

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.86
Solubility 0.214 mg/ml ; 0.00139 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.4
Solubility 0.609 mg/ml ; 0.00397 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.51
Solubility 0.047 mg/ml ; 0.000306 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.66 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.12

Application In Synthesis of [ 31270-80-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 31270-80-1 ]

[ 31270-80-1 ] Synthesis Path-Downstream   1~5

  • 1
  • [ 26956-43-4 ]
  • [ 31270-80-1 ]
YieldReaction ConditionsOperation in experiment
81% Reference Example 4 4-chlorofuro[3,2-c]pyridine; [Show Image] <strong>[26956-43-4]Furo[3,2-c]pyridin-4(5H)-one</strong> (72.2 g, 534 mmol) was added to phosphorus oxychloride (100 mL) heated to 120C, and the mixture was stirred for 30 min. The solvent was evaporated under reduced pressure. Ice-cooled water was added to the residue, and the mixture was basified with 8M aqueous sodium hydroxide solution and extracted with ethyl acetate. The extract was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure and the residue was purified by silica gel column chromatography (ethyl acetate/hexane=30/70) to give the title compound (66.1 g, yield 81%). 1H-NMR (CDCl3) delta: 7.13 (1H, dd, J = 2.2, 1.0 Hz), 7.79 (1H, dd, J = 5.8, 1.0 Hz), 8.27 (1H, d, J = 2.2 Hz), 8.32 (1H, d, J = 5.8 Hz).
With trichlorophosphate; at 120℃; for 3h; 5H-Furo [3,2-c] pyridin-4-one (5.9 g) was suspended with POCI3 (12 ml) and the reaction mixture was stirred for 3 hours at 120 C. After evaporating POCI3, crushed ice was added and poured into the mixture of ethyl acetate and saturated NaHCO3. The corresponding organic phase was separated and dried over NA2SO4 and then concentrated in vacuo. The resultant residue was purified by chromatography on a silica gel column to afford 4-chloro-furo [3,2-c] pyridine (5.6 g) 1 H NMR (400MHZ, DMSO-D6) ppm 8.31 (d, J = 5.8Hz, 1H), 8.26 (d, J = 2.3Hz, 1H), 7.79 (dd, J = 1.0, 5.6 Hz, 1H), 7.13 (dd, J=1.0, 2.3 Hz, 1 H).
With trichlorophosphate; In acetonitrile; at 110℃; for 0.0833333h;Microwave irradiation; General procedure: A solution of 6,7-dimethoxyisoquinolin-1(2H)-one(200 mg, 0.97 mmol), phosphoryl trichloride (0.268 mL, 2.92 mmol) inacetonitrile (5 mL) was stirred at 110 C for 5 minutes under microwaveirradiation. The reaction was quenched with a saturated aqueous sodium bicarbonatesolution and stirred at ambient temperature for 1 h. It was filtered throughcelite and washed with ethyl acetate. The filtrate was concentrated to dryness.The crude material was purified by flash chromatography, eluting with heptanesand ethyl acetate (1:0 to 0:1) to give the desired product as a gum (99 mg,45.4 %).
With trichlorophosphate; for 3h;Heating / reflux; [0155] Furopyridone (6,3. 26 g, 24.15 mmol) is treated with phosphorus oxychloride (10 ml) at refluxing temperature for 3 hours. After cooling, the dark solution is poured into ice and basified with aqueous sodium hydroxide to pH-9. The mixture is extracted with chloroform. After evaporation of the chloroform, the brown oil is applied to flash column chromatography on silica gel to give chlorofuropyridine as yellow crystalline solid (7).
With trichlorophosphate; at 120 - 140℃; for 2.5h; Next, Compound (3) (60.0 g, 444 mmol) and phosphorus oxychloride (POCl3) (62 mL, 666 mmol) were added into a reaction bottle. After heating the reaction bottle to 120-140 C. for 2.5 hours, the reaction bottle was cooled to 25 C. The reaction was quenched by water under ice bath. Next, the reaction mixture was neutralized with sodium hydroxide. The mixture was extracted with ethyl acetate (EA) and water. Next, an organic phase was separated and concentrated. Next, after removing water and concentrating, the result was purified by column chromatography. Compound (4) was obtained. The synthesis pathway of the above reaction was as follows:

  • 2
  • [ 31270-80-1 ]
  • [ 799293-73-5 ]
  • 3
  • [ 31270-80-1 ]
  • [ 220939-72-0 ]
YieldReaction ConditionsOperation in experiment
To the solution of 4-chloro-furo [3, 2-C] PYRIDINE (4.2 g, 0.03 mol) in CCI4 (77 ML) was added BR2 (2.4 ml, 0.046 mol) at 0C and the resultant reaction mixture was stirred for 4 hours at room temperature. The resultant suspension was poured into the mixture of ethyl acetate and 10% Na2SO3. The corresponding organic phase was separated and dried over NA2SO4 and concentrated in vacuo. The crude residue was dissolved in THF (100 ml) and DBU (1, 8-diazabicyclo [5.4. 0] undec-7-ene) (5.6 ml) was added at 0C. The resultant reaction mixture was stirred for 2 hours at room temperature and poured into NAHCO3 and ethyl acetate. The organic layers were separated, dried over anhydrous sodium sulfate, filtered and concentrated to dryness. The residue was purified by chromatography on a silica gel column to afford the titled compound (5.4 g) 1H NMR (400MHZ, CDCI3) PPM 8.32 (d, J = 5.8 Hz, 1 H), 7.72 (s, 1 H), 7.44 (d, J = 5.8 Hz, 1 H), 7.26 (s, 1 H)
  • 4
  • [ 31270-80-1 ]
  • [ 36953-42-1 ]
  • [ 220939-72-0 ]
YieldReaction ConditionsOperation in experiment
96% With sodium hydroxide; bromine; In methanol; tetrachloromethane; EXAMPLE 543A 3-bromo-4-chlorofuro[3,2-c]pyridine A solution of 4-chlorofuro[3,2-c]pyridine (commercially available, 10.60 g, 69 mmol) in carbon tetrachloride (135 mL) was cooled to -15 C. and bromine (12.13 g, 80 mmol) was added drop-wise over a fifteen minute time period. The mixture was stirred at ambient temperature for eighteen hours. The solvent was removed in vacuo, and the residue was dissolved in methanol (250 mL). A solution of 20% aqueous sodium hydroxide (35 mL) was added and the mixture was stirred 1 hour at ambient temperature. The methanol was removed in vacuo, and the residue was partitioned between water (100 mL) and dichloromethane (50 mL). The combined organic layers were dried over anhydrous magnesium sulfate and the solvent was removed in vacuo to give 3-bromo-4-chloro[3,2-c]pyridine 15.45 g, 96%) as a solid. MS (ESI(+)) m/e 232, 234 (M+H)+.
  • 5
  • [ 374790-93-9 ]
  • [ 31270-80-1 ]
  • [ 1351934-08-1 ]
YieldReaction ConditionsOperation in experiment
96% With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; palladium diacetate; lithium hydroxide; In 1,4-dioxane; water; at 80℃; for 0.5h;Inert atmosphere; General procedure: To a solution of 2-chloroheteroaryl compound 1 (0.50 mmol) in 1,4-dioxane (4.0 mL) were added pinacol boronate 3, 5, or 7 (0.60 mmol), Pd(OAc)2 (1.1 mg, 5.0 mumol), S-Phos (4.1 mg, 10.0 mumol), and 2 M LiOH solution (1.0 mL, 2.0 mmol) at room temperature, and the mixture was stirred for 30 min at 80 C under N2 atmosphere. The reaction was quenched by adding water, and then the mixture was extracted with ethyl acetate. The organic layer was washed with brine and dried over anhydrous magnesium sulfate. After filtration, the solvent was removed in vacuo, and the residue was purified by silica-gel column chromatography. The solvent was removed in vacuo, and the residue was triturated with Et2O to give biaryl compounds.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 31270-80-1 ]

Chlorides

Chemical Structure| 172152-57-7

A150413 [172152-57-7]

2-Chloro-4-methoxy-3-methylpyridine

Similarity: 0.86

Chemical Structure| 220939-72-0

A272759 [220939-72-0]

3-Bromo-4-chlorofuro[3,2-c]pyridine

Similarity: 0.82

Chemical Structure| 21560-29-2

A230597 [21560-29-2]

1-Chloro-6,7-dimethoxyisoquinoline

Similarity: 0.82

Chemical Structure| 168003-06-3

A109400 [168003-06-3]

1-Chloroisoquinolin-7-ol

Similarity: 0.79

Chemical Structure| 850197-67-0

A172804 [850197-67-0]

1-Chloroisoquinolin-6-ol

Similarity: 0.79

Related Parent Nucleus of
[ 31270-80-1 ]

Other Aromatic Heterocycles

Chemical Structure| 220939-72-0

A272759 [220939-72-0]

3-Bromo-4-chlorofuro[3,2-c]pyridine

Similarity: 0.82

Chemical Structure| 19539-50-5

A279212 [19539-50-5]

Furo[2,3-c]pyridine

Similarity: 0.63

Chemical Structure| 799293-73-5

A147000 [799293-73-5]

3-Bromofuro[3,2-c]pyridin-4-amine

Similarity: 0.58

Chemical Structure| 60290-21-3

A278896 [60290-21-3]

4-Chloro-1H-pyrrolo[3,2-c]pyridine

Similarity: 0.56

Chemical Structure| 478148-60-6

A126154 [478148-60-6]

Furo[2,3-c]pyridin-5-ylmethanol

Similarity: 0.56